🔴 Telix Pharmaceuticals is trading 4.15% down today with no new announcement explaining the decline

Telix Pharmaceuticals is trading at A$15.49, down -4.15%, with no new announcement dated August 26, 2026 explaining the decline.

• The company’s news page lists its latest 2026 release as August 5.
• Earlier August developments included strong half-year results and a newly established at-the-market equity facility; analyst concerns focused on valuation, potential dilution and competition.
• The broader biotech sector was positive, so sector strength does not explain the company-specific drop.